Can patients with borderline serous ovarian tumors receive the COVID-19 vaccine?
Dec 09, 2025
Source: Cainiu Health
Dr. Zhang Lu
Introduction
If a patient is undergoing treatments such as surgery or chemotherapy, their immune system may be weakened, making it less likely to produce effective antibodies after vaccination. Additionally, adverse reactions such as fatigue and fever may worsen, potentially interfering with the treatment process. Moreover, if the patient experiences physical discomfort such as fever or abdominal pain, or if the tumor progresses, vaccination should be temporarily suspended and priority given to managing the underlying disease.
Generally, patients with borderline serous ovarian tumors can receive the COVID-19 vaccine when their condition is stable and overall health is good. However, vaccination should be postponed during treatment or if experiencing physical discomfort. If in doubt, a comprehensive assessment is recommended before making a decision. Detailed analysis is as follows:
This type of tumor has low malignant potential. When patients are clinically stable, without significant symptoms, and have normal immune function, receiving the COVID-19 vaccine does not adversely affect the tumor. On the contrary, it provides specific protection and reduces the risk of infection, meeting the basic criteria for vaccination.
If patients are undergoing treatments such as surgery or chemotherapy, their immune systems may be weakened. In such cases, vaccination might fail to elicit an effective antibody response and could potentially worsen side effects like fatigue and fever, thereby interfering with ongoing treatment. Additionally, vaccination should be delayed if patients have symptoms such as fever or abdominal pain, or if there is evidence of tumor progression. Priority should be given to managing the underlying condition.
Prior to vaccination, patients should fully inform their healthcare provider about their tumor diagnosis, treatment status, and current health condition. A qualified medical professional should assess whether they meet the criteria for vaccination. After vaccination, patients must continue to follow standard oncology care guidelines, including regular follow-up examinations, to maintain overall health.
